Ligand validation:3BJ2

ACE: ACETYL GROUP

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3BJ2_ACE_A_0	63%	74%	0.143	0.94	0.98	0.06	-	-	6	0	100%	1
3BJ2_ACE_C_0	30%	71%	0.203	0.868	1.09	0.06	-	-	4	0	100%	1
3BJ3_ACE_A_0	40%	74%	0.185	0.897	0.93	0.1	-	-	6	0	100%	1
7KPU_ACE_B_303	99%	94%	0.056	0.986	0.42	0.03	-	-	0	0	100%	1
8ENZ_ACE_C_401	97%	94%	0.06	0.976	0.41	0.05	-	-	0	0	100%	1
8CV5_ACE_B_101	97%	78%	0.062	0.974	0.65	0.26	-	-	0	0	100%	1
8ENY_ACE_B_401	96%	71%	0.066	0.975	0.77	0.35	-	-	0	0	100%	1
8CV6_ACE_B_101	94%	79%	0.066	0.966	0.65	0.23	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.